These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37890683)

  • 1. Differentiated and non-differentiated HepaRG™ cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens.
    Gutmann M; Stimpfl E; Langmann G; Koudelka H; Mir-Karner B; Grasl-Kraupp B
    Toxicol Lett; 2023 Dec; 390():15-24. PubMed ID: 37890683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver.
    Nejabat M; Riegler T; Reitinger T; Subosits S; Römer M; Eichner J; Bilban M; Zell A; Huber WW; Schulte-Hermann R; Grasl-Kraupp B
    Arch Toxicol; 2018 Feb; 92(2):953-966. PubMed ID: 29270806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.
    Le Vee M; Jigorel E; Glaise D; Gripon P; Guguen-Guillouzo C; Fardel O
    Eur J Pharm Sci; 2006 May; 28(1-2):109-17. PubMed ID: 16488578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory mesenchymal effects of the non-genotoxic hepatocarcinogen phenobarbital: a novel mechanism of antiapoptosis and tumor promotion.
    Riegler T; Nejabat M; Eichner J; Stiebellehner M; Subosits S; Bilban M; Zell A; Huber WW; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2015 Dec; 36(12):1521-30. PubMed ID: 26378027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues.
    Hart SN; Li Y; Nakamoto K; Subileau EA; Steen D; Zhong XB
    Drug Metab Dispos; 2010 Jun; 38(6):988-94. PubMed ID: 20228232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-Mediated Gene Transfer in Differentiated HepaRG™ Cells: Expression of Liver Specific Functions and Application to the Cytochrome P450 2D6 Expression.
    Vlach M; Coppens-Exandier H; Jamin A; Berchel M; Scaviner J; Chesné C; Montier T; Jaffrès PA; Corlu A; Loyer P
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers.
    Klepeisz P; Sagmeister S; Haudek-Prinz V; Pichlbauer M; Grasl-Kraupp B; Gerner C
    PLoS One; 2013; 8(10):e76137. PubMed ID: 24204595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay.
    Seo JE; Tryndyak V; Wu Q; Dreval K; Pogribny I; Bryant M; Zhou T; Robison TW; Mei N; Guo X
    Arch Toxicol; 2019 May; 93(5):1433-1448. PubMed ID: 30788552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines.
    Seo JE; Wu Q; Bryant M; Ren L; Shi Q; Robison TW; Mei N; Manjanatha MG; Guo X
    Arch Toxicol; 2020 Jun; 94(6):2207-2224. PubMed ID: 32318794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
    Lambert CB; Spire C; Claude N; Guillouzo A
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):345-60. PubMed ID: 19084549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.
    Doktorova TY; Yildirimman R; Vinken M; Vilardell M; Vanhaecke T; Gmuender H; Bort R; Brolen G; Holmgren G; Li R; Chesne C; van Delft J; Kleinjans J; Castell J; Bjorquist P; Herwig R; Rogiers V
    Carcinogenesis; 2013 Jun; 34(6):1393-402. PubMed ID: 23393228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin.
    Okuda Y; Kushida M; Kikumoto H; Nakamura Y; Higuchi H; Kawamura S; Cohen SM; Lake BG; Yamada T
    J Toxicol Sci; 2017; 42(6):773-788. PubMed ID: 29142176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays.
    Le Hegarat L; Dumont J; Josse R; Huet S; Lanceleur R; Mourot A; Poul JM; Guguen-Guillouzo C; Guillouzo A; Fessard V
    Mutagenesis; 2010 Nov; 25(6):555-60. PubMed ID: 20675360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity assessment in HepaRG™ cells as a new approach methodology follow up to a positive response in the human TK6 cell micronucleus assay: Naphthalene case study.
    Recio L; Fowler J; Martin L; Swartz C
    Environ Mol Mutagen; 2023; 64(8-9):458-465. PubMed ID: 37704589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
    Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
    Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.
    Cerec V; Glaise D; Garnier D; Morosan S; Turlin B; Drenou B; Gripon P; Kremsdorf D; Guguen-Guillouzo C; Corlu A
    Hepatology; 2007 Apr; 45(4):957-67. PubMed ID: 17393521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
    Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1 and Benzo[a]pyrene in Human HepaRG Cells.
    Marrone AK; Tryndyak V; Beland FA; Pogribny IP
    Toxicol Sci; 2016 Feb; 149(2):496-502. PubMed ID: 26609139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.